“Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”

Press release

“Hauptstadtkongress 2024”: Medios hosts symposium on "Security of supply”

Berlin, July 01, 2024 – Medios AG, a leading provider of Specialty Pharma in Europe, was represented for the first time at the “Hauptstadtkongress” (Capital Congress) in Berlin, which took place from June 26 to June 28, 2024 and was dedicated to the key topic of "Advancing the healthcare system". With the symposium on the topic of "Security of supply for seriously ill people – are all players pulling in the same direction?", Medios initiated a multi-faceted dialog with various experts. The “Hauptstadtkongress” is the most important congress event in the German healthcare market and attracts more than 4,000 visitors every year.

Christoph Prußeit, Chief Innovation Officer of Medios AG, was joined by Thomas Weigold (Country President Sandoz Germany & CEO Hexal AG), Dirk Düvel (spokesman for the owners of "wir leben" pharmacies), Dr Klaus Gehring (specialist physician in neurology and psychiatry) and Markus Teuber (VP Partnerships, DasLab GmbH) to discuss the structural challenges of patient care for seriously or chronically ill people in Germany. Due to the diverse backgrounds of the panelists, the symposium offered a comprehensive insight into the high relevance, current situation and development opportunities of specialized care.

Christoph Prußeit, Chief Innovation Officer of Medios AG: „Healthcare in Germany is facing significant challenges. Insolvent hospitals, a shortage of qualified staff and the economic deficits of health insurance companies are placing a heavy burden on the sector and are also affecting outpatient care. In the Specialty Pharma sector in particular, it is our duty to ensure safe and comprehensive care. To achieve this, optimal cooperation between all players along the care chain – from the supplier to the dispensing pharmacy – is essential.”

Dirk Düvel, spokesman for the owners of "wir leben" pharmacies: „Specialized care is associated with both high demands and a high level of responsibility. In order to ensure comprehensive care, all stakeholders involved need to work together effectively. In partnership with Medios, more and more pharmacies in Germany can become involved in specialized care and thus significantly improve the effectiveness and efficiency of care. This is of enormous relevance, particularly in view of demographic change and the associated increase in the number of serious illnesses.“

Every year at the “Hauptstadtkongress”, experts from various fields of healthcare discuss important reform projects and set the course for the modernization of the healthcare system. The “Hauptstadtkongress 2024”, which took place from June 26 to June 28 at hub27, Messe Berlin, focused on the further development of the healthcare system. Three specialist congresses were held under the roof of the “Hauptstadtkongress”: the “Gesundheitsmanagementkongress” (Health Management Congress), the “Pflegemanagementkongress” (Nursing Management Congress) and the “Ärzteforum” (Doctors' Forum). There was also the “Hauptstadtforum Gesundheitspolitik“ (Capital City Health Policy Forum), which also included the Medios symposium.

Further information on the “Hauptstadtkongress 2024” is available here.

-------------------

About Medios AG
Medios is a leading provider of Specialty Pharma in Europe. With locations in Germany, the Netherlands, Belgium and Spain, the company supports key partners in the supply chain with innovative solutions and intelligent services. Medios has focused on pioneering individualized medicine to make the most innovative therapies available to everyone together with pharmacies, specialist practices and pharmaceutical companies.

Medios AG is Germany's first listed specialty pharmaceutical company and is listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).

www.medios.ag

Contact
Claudia Nickolaus
Head of Investor & Public Relations, ESG Communications
Medios AG
Heidestraße 9 | 10557 Berlin
T +49 30 232 566 800
ir@medios.ag
www.medios.ag